The Brazilian real (BRL) has gone from a weak BRL2.15 to a stronger BRL2.09 over the last few weeks.
Most of its assets remain in Australian companies: BRL Hardy, Fosters, McGuigan Simeon and others account for 80% of its portfolio.
It also will make for a handsome payday for the International Wine Investment Fund, a little-noticed holder of 13% of BRL's shares.
That doesn't have the Aussie wine behemoths Southcorp and BRL Hardy laughing.
Nomura Securities reiterated its recommendation on its euro-EM currency pair favorite on Tuesday, saying it is time to short the euro and buy the Brazilian real (BRL).
The dollar is down 2.7 percent against the real so far this year after gaining more than 13 percent on the BRL over the last 12 months.
Even firms that produce generic drugs such as Barr Laboratories (nyse: BRL - news - people ) are getting involved with Accenture's test program.
It is already lapping BRL Hardy's lagging Banrock Station brand.
The antidepressant's patent runs out on Aug. 2, at which point you can bet generic drugmaker Barr Laboratories (nyse: BRL - news - people) of Pomona, N.
In local rates, we find value in the front end of the curves where monetary easing is underpriced (such as Mexico MXN, Chile CLP, Brazil BRL, South Korea KRW and Poland PLN).
FORBES: Barclays Sees Global Econ Heading On "Treacherous Path"
While the BRL might not be heading to 1.50, as it looked this year, the currency is likely to strengthen short term, says head of emerging markets at Nomura Securities, Tony Volpon.
FORBES: Brazil's Currency Appreciation Trend Nearing Its End-Nomura
Generic drug maker Barr Labs (nyse: BRL - news - people ) actually sued to sell the drug earlier, and Bayer settled to keep the generic off the market.
But generic firms like Barr Labs (nyse: BRL - news - people) introduced copycats--and now branded Prozac has been hit with the largest sales erosion ever for a blockbuster drug.
But a year ago, generic drugmaker Barr Laboratories (nyse: BRL - news - people ) won a court case allowing it to make a copycat version of Prozac earlier than expected.
Fundamentally speaking, there can be little doubt that the BRL would be strong no matter what mix of policies were followed in Brazil, as even countries that favor savings over consumption are seeing their currencies appreciate.
FORBES: For Brazil's Currency, it's the Summer of 2008 Again
Goldstein expects that even if the courts slow things down, Barr Laboratories (nyse: BRL - news - people ) will start selling a cheaper generic version of Prozac come September at the latest.
The BRL recently threatened to breach the 2.15 level, its weakest in years, while the Central Bank of Brazil (BCB) has been in a fairly concerted campaign to stabilize the currency around 2.10, but not weaker than that.
Moreover, the Central Bank is likely to welcome the strengthening of the BRL, as appreciation can help ease some of the building inflationary pressure that higher food prices and a stable exchange rate were allowing to flow through to the economy.
Within healthcare, Perry is bullish on generic-drug makers like Eon Labs (nasdaq: ELAB - news - people ), Barr Laboratories (nyse: BRL - news - people ), Teva Pharmaceutical (nasdaq: TEVA - news - people ), Lannett (nyse: LCI - news - people ) and Perrigo (nasdaq: PRGO - news - people ).
应用推荐